Literature DB >> 27272903

Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration.

Vineet Gupta1, Dina V Lyne2, Marilyn Barragan3, Cory J Berkland2,4, Michael S Detamore5,6.   

Abstract

Bioceramic mixtures of tricalcium phosphate (TCP) and hydroxyapatite (HAp) are widely used for bone regeneration because of their excellent cytocompatibility, osteoconduction, and osteoinduction. Therefore, we hypothesized that incorporation of a mixture of TCP and HAp in microsphere-based scaffolds would enhance osteogenesis of rat bone marrow stromal cells (rBMSCs) compared to a positive control of scaffolds with encapsulated bone-morphogenic protein-2 (BMP-2). Poly(D,L-lactic-co-glycolic acid) (PLGA) microsphere-based scaffolds encapsulating TCP and HAp mixtures in two different ratios (7:3 and 1:1) were fabricated with the same net ceramic content (30 wt%) to evaluate how incorporation of these ceramic mixtures would affect the osteogenesis in rBMSCs. Encapsulation of TCP/HAp mixtures impacted microsphere morphologies and the compressive moduli of the scaffolds. Additionally, TCP/HAp mixtures enhanced the end-point secretion of extracellular matrix components relevant to bone tissue compared to the "blank" (PLGA-only) microsphere-based scaffolds as evidenced by the biochemical, gene expression, histology, and immunohistochemical characterization. Moreover, the TCP/HAp mixture groups even surpassed the BMP-2 positive control group in some instances in terms of matrix synthesis and gene expression. Lastly, gene expression data suggested that the rBMSCs responded differently to different TCP/HAp ratios presented to them. Altogether, it can be concluded that TCP/HAp mixtures stimulated the differentiation of rBMSCs toward an osteoblastic phenotype, and therefore may be beneficial in gradient microsphere-based scaffolds for osteochondral regeneration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27272903      PMCID: PMC5299100          DOI: 10.1007/s10856-016-5734-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  51 in total

1.  Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions.

Authors:  C Berkland; K Kim; D W Pack
Journal:  J Control Release       Date:  2001-05-18       Impact factor: 9.776

Review 2.  Leveraging "raw materials" as building blocks and bioactive signals in regenerative medicine.

Authors:  Amanda N Renth; Michael S Detamore
Journal:  Tissue Eng Part B Rev       Date:  2012-05-21       Impact factor: 6.389

3.  Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals.

Authors:  Nathan H Dormer; Milind Singh; Liang Zhao; Neethu Mohan; Cory J Berkland; Michael S Detamore
Journal:  J Biomed Mater Res A       Date:  2011-10-19       Impact factor: 4.396

4.  HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation--a long-term histological study.

Authors:  Christian Schopper; Farzad Ziya-Ghazvini; Walter Goriwoda; Doris Moser; Felix Wanschitz; Else Spassova; Georgios Lagogiannis; Alexandra Auterith; Rolf Ewers
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2005-07       Impact factor: 3.368

5.  Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface.

Authors:  Neethu Mohan; Nathan H Dormer; Kenneth L Caldwell; Vincent H Key; Cory J Berkland; Michael S Detamore
Journal:  Tissue Eng Part A       Date:  2011-08-04       Impact factor: 3.845

6.  Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering.

Authors:  Milind Singh; Casey P Morris; Ryan J Ellis; Michael S Detamore; Cory Berkland
Journal:  Tissue Eng Part C Methods       Date:  2008-12       Impact factor: 3.056

7.  Gene expression profile study on osteoinductive effect of natural hydroxyapatite.

Authors:  Xiaoying Lü; Jiandan Wang; Bin Li; Zhiwei Zhang; Lifeng Zhao
Journal:  J Biomed Mater Res A       Date:  2013-10-01       Impact factor: 4.396

8.  Technique to control pH in vicinity of biodegrading PLA-PGA implants.

Authors:  C M Agrawal; K A Athanasiou
Journal:  J Biomed Mater Res       Date:  1997

9.  Ectopic osteogenesis with biphasic ceramics of hydroxyapatite and tricalcium phosphate in rabbits.

Authors:  K Kurashina; H Kurita; Q Wu; A Ohtsuka; H Kobayashi
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

Review 10.  Perspectives in multiphasic osteochondral tissue engineering.

Authors:  June E Jeon; Cedryck Vaquette; Travis J Klein; Dietmar W Hutmacher
Journal:  Anat Rec (Hoboken)       Date:  2013-12-02       Impact factor: 2.064

View more
  4 in total

1.  Microsphere-Based Osteochondral Scaffolds Carrying Opposing Gradients Of Decellularized Cartilage And Demineralized Bone Matrix.

Authors:  Vineet Gupta; Dina V Lyne; Amy D Laflin; Taylor A Zabel; Marilyn Barragan; Joshua T Bunch; Donna M Pacicca; Michael S Detamore
Journal:  ACS Biomater Sci Eng       Date:  2016-06-23

2.  PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis.

Authors:  Patricia García-García; Ricardo Reyes; Elisabet Segredo-Morales; Edgar Pérez-Herrero; Araceli Delgado; Carmen Évora
Journal:  Pharmaceutics       Date:  2019-12-03       Impact factor: 6.321

3.  Nanohydroxyapatite-Protein Interface in Composite Sintered Scaffold Influences Bone Regeneration in Rabbit Ulnar Segmental Defect.

Authors:  Janani Radhakrishnan; Manjula Muthuraj; Gnana Santi Phani Deepika Gandham; Swaminathan Sethuraman; Anuradha Subramanian
Journal:  J Mater Sci Mater Med       Date:  2022-04-09       Impact factor: 4.727

Review 4.  Applications of Carbon Nanotubes in Bone Tissue Regeneration and Engineering: Superiority, Concerns, Current Advancements, and Prospects.

Authors:  Baoqing Pei; Wei Wang; Nicholas Dunne; Xiaoming Li
Journal:  Nanomaterials (Basel)       Date:  2019-10-22       Impact factor: 5.076

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.